| 1 |
recombinant adeno-associated virus
(1212 times)
|
Therapeutics
(303 times)
|
GFP (66 times)
CMV (34 times)
EGFP (33 times)
|
1993 Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
|
| 2 |
recombinant AAV
(92 times)
|
Virology
(29 times)
|
AAV (79 times)
AAV2 (8 times)
Ad (6 times)
|
1995 Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase.
|
| 3 |
recombinant AAV vector
(10 times)
|
Molecular Biology
(4 times)
|
AAV (8 times)
AAV2 (1 time)
Ad (1 time)
|
1999 Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.
|
| 4 |
recombinant vectors based on adeno-associated virus
(3 times)
|
Genetic Therapy
(1 time)
|
DSB (2 times)
HR (2 times)
ITRs (1 time)
|
2010 Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells.
|
| 5 |
recombinant AAV particles
(2 times)
|
Genetics, Medical
(2 times)
|
AAV (1 time)
Ad (1 time)
HPV (1 time)
|
1995 High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors.
|
| 6 |
recombinant pseudotype-1 adeno-associated virus
(2 times)
|
Molecular Biology
(2 times)
|
---
|
2007 Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.
|
| 7 |
Modular adeno-associated virus
(1 time)
|
Natural Science Disciplines
(1 time)
|
VDEPT (1 time)
|
2014 Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.
|
| 8 |
rat model of ASCI and utilized an adeno-associated virus
(1 time)
|
Cell Biology
(1 time)
|
ASCI (1 time)
miR-210 (1 time)
|
2019 Expression of miR-210 mediated by adeno-associated virus performed neuroprotective effects on a rat model of acute spinal cord injury.
|
| 9 |
recombinant adenoviral
(1 time)
|
Virology
(1 time)
|
Gal-9 (1 time)
RSV (1 time)
Th (1 time)
|
2015 Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells.
|
| 10 |
Recombinant gene delivery vehicles based on adeno-associated virus
(1 time)
|
Genetics, Medical
(1 time)
|
---
|
2005 Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
|
| 11 |
recombinant versions of AAV
(1 time)
|
Virology
(1 time)
|
AAV (1 time)
ITR (1 time)
|
2000 Induction of circular episomes during rescue and replication of adeno-associated virus in experimental models of virus latency.
|
| 12 |
renal vasculitis
(1 time)
|
Nephrology
(1 time)
|
CS (1 time)
CYC (1 time)
MF (1 time)
|
2015 Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
|
| 13 |
rep-deficient AAV vectors
(1 time)
|
Virology
(1 time)
|
AAV (1 time)
|
2014 Adeno-associated virus type 2 wild-type and vector-mediated genomic integration profiles of human diploid fibroblasts analyzed by third-generation PacBio DNA sequencing.
|
| 14 |
reported that a specific, adeno-associated viral vector
(1 time)
|
Neurology
(1 time)
|
mHTT (1 time)
RNAi (1 time)
|
2008 Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivo.
|
| 15 |
therefore an attractive possibility, with vectors based on adeno-associated virus
(1 time)
|
Genetics, Medical
(1 time)
|
ash (1 time)
OTC (1 time)
|
2013 AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.
|
A Search Service for Abbreviation / Long Form